News: Adaptimmune Therapeutics Plc ADR’s Chief Commercial Officer Piccina Cintia reduceds 24,531 shares
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Commercial Officer Piccina Cintia unloaded Company’s shares for reported $22814.0